Press Play with Madeleine Brand
UCLA doctor on leading Remdesivir trials as possible COVID-19 treatment
The National Institutes of Health is sponsoring 75 clinical trials across the world for a possible treatment for COVID-19. They’re all testing a drug called Remdesivir, which was originally developed as treatment for Ebola.
By Madeleine Brand • • 1 min readThe National Institutes of Health is sponsoring 75 clinical trials across the world for a possible treatment for COVID-19. They’re all testing a drug called Remdesivir, which was originally developed as treatment for Ebola. Some of those trials are happening at UCSF, Stanford and UCLA. We speak with UCLA’s Dr. Otto Yang, who’s heading the trial.
